Megakaryocytes harbour the del(5q) abnormality despite complete clinical and cytogenetic remission induced by lenalidomide treatment

JSON

Scharenberg C, Jansson M, Saft L, Hellström-Lindberg E

Br J Haematol 180 (4) 526-533 [2018-02-00; online 2018-01-29]

Clinical Genomics Uppsala [Service]

PubMed 29377069

DOI 10.1111/bjh.15094

Crossref 10.1111/bjh.15094